Fischer Medical Ventures Limited is an India-based company. The Company specializes in trading and manufacturing of magnetic resonance imaging (MRI) systems. It is engaged in the development of advanced medical diagnostic and imaging technologies, through its wholly owned subsidiary, Time Medical International Ventures (India) Private Limited. It comprises a manufacturing facility that can produce 160 MRI machines per year. It provides a comprehensive range of healthcare solutions across various specialties, namely Ophthalmology, Cardiology, Oncology, Dentistry, Neurology, Mental Health, and Point of Care. The Company's products include PICA, MONA, EMMA, NEONA, and NOVA.
FISCHER MEDICAL VENTURE L Financial Highlights
- Revenue: FISCHER MEDICAL VENTURE L reported revenue of ₹320.89 crore in FY26 vs ₹112.19 crore in FY25. It showed an increase of 186.02% on a yearly basis.
- Operating Profit: FISCHER MEDICAL VENTURE L reported an operating profit of ₹46.58 crore in FY26 vs ₹2.71 crore in FY25. It showed an increase of 1,618.82% on a year-on-year basis.
- Net Profit: FISCHER MEDICAL VENTURE L reported a net profit of ₹31.24 crore in FY26 vs ₹1.69 crore in FY25. It showed an increase of 1,748.52% on a yearly basis.
FISCHER MEDICAL VENTURE L Quarterly Result Highlights
- FISCHER MEDICAL VENTURE L reported revenue of ₹99.01 crore in Mar 2026, compared with ₹102.19 crore in Dec 2025, representing a decrease of 3.11% on a quarter-on-quarter (QoQ) basis.
- FISCHER MEDICAL VENTURE L reported an operating loss of ₹2.25 crore in Mar 2026, compared with ₹21.25 crore in Dec 2025, representing a decrease of 110.59% on a quarter-on-quarter (QoQ) basis.
- FISCHER MEDICAL VENTURE L reported a loss of ₹7.11 crore in Mar 2026, compared with ₹19.29 crore in Dec 2025, reflecting a decrease of 136.86% on a QoQ basis.
- The earnings per share (EPS) of FISCHER MEDICAL VENTURE L stood at ₹0.08 during Mar 2026.